GLYCOMAB

Welcome to the Brand page for “GLYCOMAB”, which is offered here for In the statement, column 2, line 5, 774420 should be deleted, and, 492191 should be inserted;development of new technologies for others in the field of biotechnology and pharmaceutical industry; research and development services in the field of glycosylation of monoclonal antibodies for pharmaceutical and biotechnological companies;.

Its status is currently believed to be active. Its class is unavailable. “GLYCOMAB” is believed to be currently owned by “Glycart Biotechnology AG”.


Owner:
GLYCART BIOTECHNOLOGY AG
Owner Details
Description:
In the statement, column 2, line 5, 774420 should be deleted, and, 492191 should be inserted;development of new technologies for others in the field of biotechnology and pharmaceutical industry; research and development services in the field of glycosylation of monoclonal antibodies for pharmaceutical and biotechnological companies;
Categories: STATEMENT